Could intensive screening for gonorrhoea/chlamydia in PrEP cohorts select for resistance? Historical lessons from a mass treatment campaign in Greenland.
Neisseria gonorrhoeae has developed resistance to all classes of antimicrobials used against it. Current strategies to prevent the emergence of pan-resistance include increased gonorrhoea screening in high prevalence populations such as men who have sex with men taking HIV preexposure prophylaxis. By increasing antimicrobial exposure, others have argued that intensive screening may inadvertently promote the emergence of antimicrobial resistance. To contribute to this discussion, we conducted a historical review of the effect of a mass gonorrhoea treatment campaign in Greenland from 1965-1968 on the incidence of gonorrhoea and antimicrobial resistance. We conducted a literature review using PUBMED and Google Scholar to find relevant studies. Data on the incidence of gonorrhoea, antimicrobial susceptibility and antimicrobials dispensed were extracted and analyzed. Eight papers were found with relevant information. The cornerstone of the campaign involved the repeated treatment of all persons with a diagnosis of gonorrhoea in the past 6 months as well as all remaining unmarried persons between 15 and 30 years of age. There was a small and temporary decline in the incidence of gonorrhoea during the campaign. The campaign was, however, associated with an increase in the proportion of gonococci that were not susceptible to penicillin. Gonococcal incidence continued to climb after the campaign ended but did decline dramatically following reductions in risk behavior following the global AIDS epidemic. The mass gonorrhoea treatment campaign in Greenland was associated with only a temporary decline in the incidence of gonorrhoea. It was, however, followed by an increase in penicillin non-susceptibility. Intense gonorrhoea screening and treatment strategies should be aware of the risk of inducing antimicrobial resistance.